King Khaled Eye Specialist Hospital, Riyadh.
Faculty of Ophthalmology, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
J Glaucoma. 2020 Dec;29(12):1173-1178. doi: 10.1097/IJG.0000000000001661.
In this matched case-control study, ligature of the Ahmed glaucoma valve (AGV) was associated with a reduction in the rate of postoperative complications without affecting the surgical success rate or the visual outcome following the procedure.
The purpose of this study was to compare the safety and efficacy of AGV surgery with and without tube ligation.
This was a retrospective, matched case-control study. A review was performed of patients who underwent AGV surgery with tube ligation between June 2015 and December 2017 (ligated AGV group). Cases were matched with controls who underwent AGV surgery without tube ligation (nonligated AGV group). Data were compared on postoperative intraocular pressure (IOP), the number of glaucoma medications, surgical success rates, complications, and vision.
There were 49 eyes in the ligated AGV group, and 98 eyes in the nonligated AGV group. Baseline characteristics were similar between groups except for the number of glaucoma medications (3.72±0.55 in the ligated AGV group vs. 3.92±0.92 in the nonligated AGV group; P<0.01). At 18 months, IOP was 16.7±6.3 mm Hg in the ligated AGV group and 17.3±8.0 mm Hg in the nonligated AGV group (P=0.76). In addition, the mean number of glaucoma medications was 2.38±1.10 in the ligated AGV group and 1.68±1.51 in the nonligated AGV group (P=0.56). The overall success rate at 12 months was similar between groups (P=0.84). The overall rate of complications was statistically lower in the ligated AGV group (28.6%) compared with the nonligated AGV group (73.5%) (P<0.01). The mean change in logarithm of the minimum angle of resolution acuity was similar between groups (P=0.50).
Tube ligation in AGV surgery may be an effective measure that reduces the rate of postoperative complications without affecting the success rate or visual outcomes of the surgery.
在这项匹配病例对照研究中, Ahmed 青光眼引流阀(AGV)结扎与降低术后并发症发生率相关,而不影响手术成功率或术后视力结果。
本研究旨在比较带管结扎和不带管结扎的 AGV 手术的安全性和有效性。
这是一项回顾性、匹配病例对照研究。对 2015 年 6 月至 2017 年 12 月期间行 AGV 手术带管结扎的患者(结扎 AGV 组)进行了回顾。将病例与行 AGV 手术不带管结扎的对照组患者(非结扎 AGV 组)进行匹配。比较两组术后眼压(IOP)、青光眼药物数量、手术成功率、并发症和视力。
结扎 AGV 组有 49 只眼,非结扎 AGV 组有 98 只眼。两组间的基线特征相似,除青光眼药物数量外(结扎 AGV 组 3.72±0.55 只,非结扎 AGV 组 3.92±0.92 只;P<0.01)。在 18 个月时,结扎 AGV 组的 IOP 为 16.7±6.3mmHg,非结扎 AGV 组为 17.3±8.0mmHg(P=0.76)。此外,结扎 AGV 组的平均青光眼药物数量为 2.38±1.10 只,非结扎 AGV 组为 1.68±1.51 只(P=0.56)。12 个月时两组的总体成功率相似(P=0.84)。结扎 AGV 组的总并发症发生率明显低于非结扎 AGV 组(28.6%比 73.5%)(P<0.01)。两组间最小分辨角视力对数变化的平均值相似(P=0.50)。
AGV 手术中带管结扎可能是一种有效的措施,可降低术后并发症发生率,而不影响手术成功率或手术视力结果。